Loading…
ProKidney Corp. is projected to rise to $1.64 by 2027, a +6% move from its current price of $1.54. PROK is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $1.50 | $1.54 | $1.59 | 0.00% |
| Aug 4 | $1.48 | $1.54 | $1.61 | +0.01% |
| Aug 5 | $1.46 | $1.54 | $1.62 | +0.01% |
| Aug 6 | $1.45 | $1.54 | $1.63 | +0.02% |
| Aug 7 | $1.44 | $1.54 | $1.64 | +0.02% |
| Aug 8 | $1.43 | $1.54 | $1.65 | +0.03% |
| Aug 9 | $1.43 | $1.54 | $1.66 | +0.03% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.43 | $1.54 | $1.66 | +0.03% |
| Week 2 | $1.38 | $1.54 | $1.72 | +0.06% |
| Week 3 | $1.35 | $1.54 | $1.76 | +0.09% |
| Week 4 | $1.32 | $1.54 | $1.80 | +0.12% |
| Week 5 | $1.30 | $1.54 | $1.83 | +0.15% |
| Week 6 | $1.28 | $1.54 | $1.86 | +0.18% |
| Week 7 | $1.26 | $1.54 | $1.89 | +0.21% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ProKidney Corp. is a clinical-stage biotechnology company focused on cell therapies for chronic kidney diseases in the United States. The company develops rilparencel, a cell therapy with autologous selected renal cells, which is in Phase III clinical trial for the treatment of advanced chronic kidney disease and type 2 diabetes.
It is also involved in the development of cryopreserved versions of rilparencel, including REGEN-006 and REGEN-008 which are both in Phase III clinical trials; REGEN-002, REGEN-003, and REGEN-007 which are in Phase II clinical trials; and REGEN-004 which is Phase I clinical trial.
The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
ProKidney Corp. (PROK) is a healthcare company with a current price of $1.60 and a market cap of $483.3M. Its market position is reflected by a rank of 3084. The stock trades within a provided forecast path that shows a neutral near term and bullish long-term outlook, with average price levels rising from $1.60 in 2026 to higher levels in later years.
Forecasts show quick expansion in the later years, with 2032, 2033, and beyond presenting bullish levels. The average prices and corresponding ROI figures include 2032 avg $2.07 with a 29.6% ROI, 2040 avg $3.30 with a 106.5% ROI, and 2050 avg $4.33 with a 170.6% ROI, indicating meaningful upside over the multi-year horizon.
A major floor 25.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.6% away) — a key level to hold.
The nearest ceiling, 32.5% above — a clean break opens room to run.
A major ceiling 45.0% above — clearing it would confirm fresh momentum.
Key PROK support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PROK market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.55 | Sell | $1.55 | Sell |
| MA 10 | $1.54 | Sell | $1.57 | Sell |
| MA 20 | $1.64 | Sell | $1.62 | Sell |
| MA 50 | $1.73 | Sell | $1.71 | Sell |
| MA 100 | $1.82 | Sell | $1.82 | Sell |
| MA 200 | $2.11 | Sell | $1.95 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.86 | Neutral |
| Stoch RSI (14) | 61.58 | Neutral |
| CCI (20) | -57.43 | Neutral |
| Williams %R (14) | -66.67 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -3.75 | Sell |
| Bollinger %B (20,2) | 0.33 | Neutral |
| Stochastic %K (14) | 33.33 | Neutral |
| TRIX (15) | -0.53 | Sell |
| Awesome (5,34) | -0.16 | Sell |
| Ultimate (7,14,28) | 48.39 | Neutral |
| Momentum (10) | -0.08 | Sell |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 1.56 | Sell |
| ADX (14) | 17.48 | Neutral |
| ATR (14) | 0.04 | Info |
The 30-day picture is bearish with RSI14 at 40. The 50-day moving average is $1.78 and the 200-day moving average is $2.18. A key support level sits at $1.55 and resistance at $2.04. The 30-day range spans from $1.25 to $2.05, reflecting a constrained trading window in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.50 | $1.54 | $2.01 | 0% | Neutral | |
| $1.30 | $1.64 | $2.19 | +6% | Neutral | |
| $1.32 | $1.72 | $2.39 | +11% | Neutral | |
| $1.24 | $1.66 | $2.38 | +8% | Neutral | |
| $1.20 | $1.64 | $2.42 | +7% | Neutral | |
| $1.26 | $1.75 | $2.64 | +14% | Neutral | |
| $1.49 | $2.12 | $3.25 | +37% | Bullish | |
| $1.62 | $2.33 | $3.66 | +52% | Bullish | |
| $1.54 | $2.26 | $3.59 | +47% | Bullish | |
| $1.57 | $2.34 | $3.79 | +52% | Bullish | |
| $2.06 | $3.30 | $5.70 | +115% | Bullish | |
| $2.65 | $4.83 | $9.16 | +214% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.50 | $1.54 | $1.92 | +0.00% |
| September 2026 | $1.33 | $1.58 | $1.93 | +2.64% |
| October 2026 | $1.29 | $1.55 | $1.91 | -2.19% |
| November 2026 | $1.31 | $1.58 | $1.96 | +1.99% |
| December 2026 | $1.32 | $1.60 | $2.01 | +1.46% |
Click any year to see its month-by-month PROK forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PROK is projected to trade between $1.50 and $2.01, averaging $1.54 — a potential gain of 0% from today's $1.54. A consolidation phase looks the most probable path here.
ProKidney Corp.'s 2027 outlook centres on $1.64, within a $1.30 to $2.19 range. That is up +6% on the projected 2026 average. That marks a +6% change versus current levels. Price action looks broadly range-bound.
By 2028, PROK could reach as high as $2.39, with a base case around $1.72 and support toward $1.32 — roughly +11% from $1.54. A consolidation phase looks the most probable path here.
Expect PROK to range from $1.24 to $2.38 through 2029. The $1.66 average target implies a +8% move from current prices. That is -3% versus the projected 2028 average. Price action looks broadly range-bound.
The PROK price prediction for 2030 points to an average of $1.64 (low $1.20, high $2.42) — a potential gain of +7% on today's $1.54. A consolidation phase looks the most probable path here.
In 2031, PROK is projected to trade between $1.26 and $2.64, averaging $1.75 — a potential gain of +14% from today's $1.54. That is up +7% on the projected 2030 average. Price action looks broadly range-bound.
ProKidney Corp.'s 2032 outlook centres on $2.12, within a $1.49 to $3.25 range. That is up +21% on the projected 2031 average. That marks a +37% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, PROK could reach as high as $3.66, with a base case around $2.33 and support toward $1.62 — roughly +52% from $1.54. Momentum favours further upside here.
Expect PROK to range from $1.54 to $3.59 through 2034. The $2.26 average target implies a +47% move from current prices. That is -3% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
The PROK price prediction for 2035 points to an average of $2.34 (low $1.57, high $3.79) — a potential gain of +52% on today's $1.54. Momentum favours further upside here.
In 2040, PROK is projected to trade between $2.06 and $5.70, averaging $3.30 — a potential gain of +115% from today's $1.54. That is up +41% on the projected 2035 average. Buyers look set to stay in control over this stretch.
ProKidney Corp.'s 2050 outlook centres on $4.83, within a $2.65 to $9.16 range. That is up +46% on the projected 2040 average. That marks a +214% change versus current levels. Momentum favours further upside here.
Investing $1,000 in PROK today (≈ 649.350649 PROK) could be worth
$3,136.76
+$2,136.76 (+214%) by 2050 · US Dollar
Based on the average projected PROK price of $4.83 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PROKwould be worth at today's price.
$1,000 invested in PROK on Jul 31, 2025 (≈ 361.010833 PROK) would be worth
$555.96
-$444.04 (-44.4%) today · 0.56× · US Dollar
Based on a PROK entry price of $2.77 vs. today's $1.54.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.5 | $1,026.67 | +2.7% |
| 1 month ago | $1.89 | $814.81 | -18.5% |
| 3 months ago | $1.93 | $797.93 | -20.2% |
| 6 months ago | $2.04 | $754.9 | -24.5% |
| 1 year ago | $2.77 | $555.96 | -44.4% |
| All time (5.0y) ago | $9.89 | $155.71 | -84.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PROK forecast.
Our base-case forecast reaches $3.10 around 2040.
Implied market cap at $3.10: $636.12M
The multi-year forecast shows a shift from neutral to bullish in the later years. In 2026 the min/avg/max prices are $1.55/$1.60/$2.14 with a 0% ROI and Neutral sentiment. By 2032 the average rises to $2.07 and the max to $3.42, delivering a 29.6% ROI and a Bullish outlook.
The forecast then strengthens further, with 2033 at $2.34 average and 2034 at $2.27 average, both Bullish, and 2040 at $3.30 average with a 106.5% ROI. By 2050 the average is $4.33 with a 170.6% ROI and a Bullish sentiment. These numbers imply meaningful upside potential across the extended horizon, though 2030 shows a modest negative ROI of -1.6% with an average of $1.57.
The volatility implied by the long-run figures aligns with a high-variance outlook across years.
Tap a question to reveal the answer.
The forecast for 2030 shows a min price of $1.09, an average price of $1.57, and a max price of $2.47, with a ROI of -1.6% and Neutral sentiment.
Near term is Neutral, with a current price of $1.60 and a market cap of $483.3M. Long term shows Bullish potential from 2032 onward, with averages reaching $2.07 by 2032, $3.30 by 2040, and $4.33 by 2050, and ROIs of 29.6%, 106.5%, and 170.6% respectively.
Yes. The forecast for 2033 shows a max price of $3.96, with an average of $2.34, indicating price potential above $3 in that year.
Current price is $1.60 and market cap is $483.3M.
The near-term technicals show a bearish sentiment with RSI of 40, a 50-day SMA of $1.78, a 200-day SMA of $2.18, a support at $1.55, a resistance at $2.04, and a 30-day price range of $1.25 to $2.05.
ProKidney Corp. Community Discussion
0Share your ProKidney Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.